Cancer/Genetics

Study Looks at Factor That May Reverse Leukemia

Published in Gene Therapy Weekly, February 27th, 1995

According to a study by Vanderbilt University Medical Center, Nashville, Tennessee, the key to gene therapy for at least two forms of leukemia may lie in the mechanics of a natural carcinogen in our cells, said one researcher.

Dr. Lawrence D. Kerr, assistant professor of Microbiology and Immunology and Cell Biology, believes the multi-protein complex Nuclear Factor kappa-B (NF-kB), a ubiquitous transcription factor found in each cell of the human body, has the power to cause and the potential to reverse certain cancers.

"An understanding of the factors and signals which regulate NF-kB activity is of paramount importance to the study of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (1995-02-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry